{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:59:26Z","timestamp":1773694766675,"version":"3.50.1"},"reference-count":127,"publisher":"Oxford University Press (OUP)","issue":"Supplement_J","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Cancer Society Mentored Research Scholar Grant","award":["MRSG-17-220-01\u2014NEC"],"award-info":[{"award-number":["MRSG-17-220-01\u2014NEC"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R00 CA215314"],"award-info":[{"award-number":["R00 CA215314"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amarin Pharma, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The REDUCE-IT trial demonstrated that icosapent ethyl, an ethyl ester of eicosapentaenoic acid (EPA), reduced cardiovascular events in an at-risk population by a substantial degree. While the cardiovascular protective properties of this compound are now proven, several other potential uses are being actively explored in clinical studies. These areas of investigation include cancer, inflammatory bowel disease, infections, Alzheimer\u2019s disease, dementia, and depression. The next decade promises to deepen our understanding of the beneficial effects that EPA may offer beyond cardiovascular risk reduction.<\/jats:p>","DOI":"10.1093\/eurheartj\/suaa119","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T16:44:22Z","timestamp":1602002662000},"page":"J54-J64","source":"Crossref","is-referenced-by-count":12,"title":["Beyond cardiovascular medicine: potential future uses of icosapent ethyl"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L","family":"Bhatt","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Heart & Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Hull","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal and Surgical Sciences, Leeds Institute of Medical Research, St James\u2019s University Hospital, University of Leeds, Leeds, LS9 7TF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyang","family":"Song","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA"},{"name":"Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Boston, MA 02114, USA"},{"name":"Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, 50 Fruit Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Van Hulle","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Carlsson","sequence":"additional","affiliation":[{"name":"William S. Middleton Memorial Veterans Hospital, Madison VA Geriatric Research, Education and Clinical Center (GRECC), 2500 Overlook Terrace, Madison, WI 53705, USA"},{"name":"Division of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Disease Research Center (ADRC), 600 Highland Ave, J5\/1 Mezzanine, Madison, WI 53792, USA"},{"name":"Wisconsin Alzheimer\u2019s Institute (WAI), 610 Walnut St Suite 957, Madison, WI 53726, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M John","family":"Chapman","sequence":"additional","affiliation":[{"name":"Sorbonne University, 21, Rue de l'Ecole de Medicine, 75006 Paris, France"},{"name":"Endocrinology-Metabolism Division, Pitie-Salpetriere University Hospital, 47-83, Boulevard de lopital, 75651 Paris Cedex, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P","family":"Toth","sequence":"additional","affiliation":[{"name":"CGH Medical Center, 101 East Miller Road, Sterling, IL 61081, USA"},{"name":"Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"2020100612441520700_suaa119-B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"2020100612441520700_suaa119-B2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/clc.22692","article-title":"Rationale and design of REDUCE-IT: reduction of cardiovascular events with icosapent ethyl-intervention trial","volume":"40","author":"Bhatt","year":"2017","journal-title":"Clin Cardiol"},{"key":"2020100612441520700_suaa119-B3","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.jacc.2019.02.032","article-title":"Effects of icosapent ethyl on total ischemic events: from REDUCE-IT","volume":"73","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2020100612441520700_suaa119-B4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.119.044440","article-title":"REDUCE-IT USA: results from the 3,146 patients randomized in the United States","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"key":"2020100612441520700_suaa119-B5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2018.04.061","article-title":"Unmet need for adjunctive dyslipidemia therapy in hypertriglyderidemia management","volume":"72","author":"Ganda","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2020100612441520700_suaa119-B6","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehz179","article-title":"REDUCE-IT: residual cardiovascular risk in statin-treated patients with elevated triglycerides: now we can REDUCE-IT!","volume":"40","author":"Bhatt","year":"2019","journal-title":"Eur Heart J"},{"key":"2020100612441520700_suaa119-B7","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/eurheartj\/ehz778","article-title":"Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics","volume":"41","author":"Boden","year":"2020","journal-title":"Eur Heart J"},{"key":"2020100612441520700_suaa119-B8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/HCO.0000000000000678","article-title":"Cardiovascular risk reduction with icosapent ethyl","volume":"34","author":"Patel","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"2020100612441520700_suaa119-B9","doi-asserted-by":"crossref","DOI":"10.1002\/clc.23437","article-title":"Applicability of the REDUCE-IT trial to the FAST-MI registry. Are the results of randomized trials relevant in routine clinical practice?","author":"Ferri\u00e8res","year":"2020","journal-title":"Clin Cardiol"},{"key":"2020100612441520700_suaa119-B10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2019.01.016","article-title":"Generalizability of the REDUCE-IT trial in patients with stable coronary artery disease","volume":"73","author":"Picard","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2020100612441520700_suaa119-B11","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2020.08.015","article-title":"REDUCE-IT eligibility and preventable cardiovascular events in the US population (from the National Health and Nutrition Examination Survey [NHANES])","author":"Wong","year":"2020","journal-title":"Am J Cardiol"},{"key":"2020100612441520700_suaa119-B12","first-page":"29","article-title":"Eicosapentaenoic acid: atheroprotective properties and the reduction of atherosclerotic cardiovascular disease events","volume":"5","author":"Pisaniello","year":"2020","journal-title":"EMJ"},{"key":"2020100612441520700_suaa119-B13","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jacc.2019.08.007","article-title":"Reply: ischemic event reduction and triglycerides","volume":"74","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2020100612441520700_suaa119-B14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.06.043","article-title":"Reduction in first and total ischemic events with icosapent ethyl across baseline triglyceride tertiles","volume":"74","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2020100612441520700_suaa119-B15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jchf.2019.03.008","article-title":"Predicting risk for incident heart failure with omega-3 fatty acids: from MESA","volume":"7","author":"Block","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2020100612441520700_suaa119-B16","volume-title":"Vascepa [Package Insert]","year":"2019"},{"key":"2020100612441520700_suaa119-B17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11886-020-01356-4","article-title":"Icosapent ethyl: Niche drug or for the masses?","volume":"22","author":"Bazarbashi","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"2020100612441520700_suaa119-B18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.atherosclerosis.2015.07.035","article-title":"Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis","volume":"242","author":"Borow","year":"2015","journal-title":"Atherosclerosis"},{"key":"2020100612441520700_suaa119-B19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/gut.2010.233718","article-title":"Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer","volume":"61","author":"Cockbain","year":"2012","journal-title":"Gut"},{"key":"2020100612441520700_suaa119-B20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.2009.200642","article-title":"Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis","volume":"59","author":"West","year":"2010","journal-title":"Gut"},{"key":"2020100612441520700_suaa119-B21","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/S0140-6736(18)31775-6","article-title":"Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 x 2 factorial trial","volume":"392","author":"Hull","year":"2018","journal-title":"Lancet"},{"key":"2020100612441520700_suaa119-B22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/jamaoncol.2019.4587","article-title":"Effect of supplementation with marine omega-3 fatty acid on risk of colorectal adenomas and serrated polyps in the US general population: a prespecified ancillary study of a randomized clinical trial","volume":"6","author":"Song","year":"2020","journal-title":"JAMA Oncol"},{"key":"2020100612441520700_suaa119-B23","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gutjnl-2013-306445","article-title":"Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid","volume":"63","author":"Cockbain","year":"2014","journal-title":"Gut"},{"key":"2020100612441520700_suaa119-B24","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gutjnl-2016-311990","article-title":"Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis","volume":"66","author":"Song","year":"2017","journal-title":"Gut"},{"key":"2020100612441520700_suaa119-B25","doi-asserted-by":"crossref","first-page":"S-787","DOI":"10.1016\/S0016-5085(18)32712-4","article-title":"Postdiagnosis marine omega-3 fatty acid intake and survival of stage III colon cancer in North Center Cancer Treatment Group (NCCTG) phase III trial N0147 (Alliance) [abstract Mo1730]","volume":"154","author":"Song","year":"2018","journal-title":"Gastroenterology"},{"key":"2020100612441520700_suaa119-B26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcn\/nqz281","article-title":"Effects of perioperative intravenous omega-3 fatty acids in colon cancer patients: a randomized, double-blind, placebo-controlled clinical trial","volume":"111","author":"Bakker","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"2020100612441520700_suaa119-B27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease","volume":"334","author":"Belluzzi","year":"1996","journal-title":"N Engl J Med"},{"key":"2020100612441520700_suaa119-B28","first-page":"CD006320","article-title":"Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease","volume":"2","author":"Lev-Tzion","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020100612441520700_suaa119-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-019-01901-0","article-title":"Dietary intake of fish, n-3 polyunsaturated fatty acids, and risk of inflammatory bowel disease: a systematic review and meta-analysis of observational studies","volume":"59","author":"Mozaffari","year":"2020","journal-title":"Eur J Nutr"},{"key":"2020100612441520700_suaa119-B30","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.cgh.2018.01.036","article-title":"Eicosapentaenoic acid reduces fecal levels of calprotectin and prevents relapse in patients with ulcerative colitis","volume":"16","author":"Scaioli","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020100612441520700_suaa119-B31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cgh.2018.07.012","article-title":"Environmental factors, gut microbiota, and colorectal cancer prevention","volume":"17","author":"Song","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020100612441520700_suaa119-B32","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1136\/gutjnl-2017-314968","article-title":"A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota","volume":"67","author":"Watson","year":"2018","journal-title":"Gut"},{"key":"2020100612441520700_suaa119-B33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"key":"2020100612441520700_suaa119-B34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterol"},{"key":"2020100612441520700_suaa119-B35","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1038\/srep11276","article-title":"A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia","volume":"5","author":"Kaliannan","year":"2015","journal-title":"Sci Rep"},{"key":"2020100612441520700_suaa119-B36","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.3748\/wjg.v20.i42.15650","article-title":"Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity","volume":"20","author":"Estaki","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2020100612441520700_suaa119-B37","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.0914730107","article-title":"Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification","volume":"107","author":"Campbell","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020100612441520700_suaa119-B38","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"2020100612441520700_suaa119-B39","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4049\/jimmunol.1100150","article-title":"Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators","volume":"187","author":"Campbell","year":"2011","journal-title":"J Immunol"},{"key":"2020100612441520700_suaa119-B40","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/JB.88.4.1056-1064.1964","article-title":"Biohydrogenation of unsaturated fatty acids by rumen bacteria","volume":"88","author":"Polan","year":"1964","journal-title":"J Bacteriol"},{"key":"2020100612441520700_suaa119-B41","doi-asserted-by":"crossref","first-page":"17808","DOI":"10.1073\/pnas.1312937110","article-title":"Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition","volume":"110","author":"Kishino","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020100612441520700_suaa119-B42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2014.12.036","article-title":"Food, immunity, and the microbiome","volume":"148","author":"Tilg","year":"2015","journal-title":"Gastroenterology"},{"key":"2020100612441520700_suaa119-B43","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.immuni.2014.05.015","article-title":"Finding the missing links among metabolites, microbes, and the host","volume":"40","author":"Dorrestein","year":"2014","journal-title":"Immunity"},{"key":"2020100612441520700_suaa119-B44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","article-title":"Microbes, microbiota, and colon cancer","volume":"15","author":"Sears","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2020100612441520700_suaa119-B45","volume-title":"Major Infectious Diseases","author":"Holmes","year":"2017"},{"key":"2020100612441520700_suaa119-B46","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"2020100612441520700_suaa119-B47","doi-asserted-by":"crossref","first-page":"109794","DOI":"10.1016\/j.chaos.2020.109794","article-title":"Modeling and forecasting of epidemic spreading: the case of Covid-19 and beyond","volume":"135","author":"Boccaletti","year":"2020","journal-title":"Chaos Solitons Fractals"},{"key":"2020100612441520700_suaa119-B48","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/CCM.0000000000004247","article-title":"Epigenetics of sepsis","volume":"48","author":"Binnie","year":"2020","journal-title":"Crit Care Med"},{"key":"2020100612441520700_suaa119-B49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1631\/jzus.B1700063","article-title":"Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens","volume":"19","author":"Chanda","year":"2018","journal-title":"J Zhejiang Univer Sci B"},{"key":"2020100612441520700_suaa119-B50","volume-title":"Lipids and Essential Oils as Antimicrobial Agents","author":"Thormar","year":"2010"},{"key":"2020100612441520700_suaa119-B51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaad.2013.01.016","article-title":"The skin microbiome: current perspectives and future challenges","volume":"69","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2020100612441520700_suaa119-B52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbamem.2014.04.020","article-title":"How polyunsaturated fatty acids modify molecular organization in membranes: insight from NMR studies of model systems","volume":"1848","author":"Shaikh","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2020100612441520700_suaa119-B53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/9783527665259.ch20","volume-title":"Marine Microbiology","author":"Desbois","year":"2013"},{"key":"2020100612441520700_suaa119-B54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.2041-1014.2009.00553.x","article-title":"A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives","volume":"25","author":"Huang","year":"2010","journal-title":"Mol Oral Microbiol"},{"key":"2020100612441520700_suaa119-B55","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/ijms19041114","article-title":"Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications","volume":"19","author":"Yoon","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2020100612441520700_suaa119-B56","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.lwt.2006.12.005","article-title":"Antibacterial activity of eicosapentaenoic acid (EPA) against foodborne and food spoilage microorganisms","volume":"40","author":"Shin","year":"2007","journal-title":"LWT Food Sci Technol"},{"key":"2020100612441520700_suaa119-B57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrmicro1839","article-title":"Membrane lipid homeostasis in bacteria","volume":"6","author":"Zhang","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"2020100612441520700_suaa119-B58","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00253-009-2355-3","article-title":"Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential","volume":"85","author":"Desbois","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"2020100612441520700_suaa119-B59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/md15110334","article-title":"Antibacterial effect of eicosapentaenoic acid against Bacillus cereus and Staphylococcus aureus: killing kinetics, selection for resistance, and potential cellular target","volume":"15","author":"Le","year":"2017","journal-title":"Mar Drugs"},{"key":"2020100612441520700_suaa119-B60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3904\/kjim.2016.31.1.30","article-title":"The antibacterial effect of fatty acids on Helicobacter pylori infection","volume":"31","author":"Jung","year":"2015","journal-title":"Korean J Intern Med"},{"key":"2020100612441520700_suaa119-B61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/AAC.31.1.27","article-title":"Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides","volume":"31","author":"Thormar","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"2020100612441520700_suaa119-B62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2004.04.019","article-title":"Anti-HCV activities of selective polyunsaturated fatty acids","volume":"318","author":"Leu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2020100612441520700_suaa119-B63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.arcmed.2020.03.004","article-title":"Can bioactive lipids inactivate coronavirus (COVID-19)?","volume":"51","author":"Das","year":"2020","journal-title":"Arch Med Res"},{"key":"2020100612441520700_suaa119-B64","author":"Berger","year":"2020"},{"key":"2020100612441520700_suaa119-B65","year":"2020"},{"key":"2020100612441520700_suaa119-B66","year":"2020"},{"key":"2020100612441520700_suaa119-B67","year":"2020"},{"key":"2020100612441520700_suaa119-B68","year":"2020"},{"key":"2020100612441520700_suaa119-B69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"2020100612441520700_suaa119-B70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory\u2013pro-resolving mediators and their receptors","volume":"11","author":"Serhan","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"2020100612441520700_suaa119-B71","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"2020100612441520700_suaa119-B72","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bph.14336","article-title":"Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology","volume":"176","author":"Dalli","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2020100612441520700_suaa119-B73","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"Chem Biol"},{"key":"2020100612441520700_suaa119-B74","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Invest"},{"key":"2020100612441520700_suaa119-B75","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.0901809","article-title":"The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury","volume":"184","author":"Seki","year":"2010","journal-title":"J Immunol"},{"key":"2020100612441520700_suaa119-B76","first-page":"321","article-title":"Alzheimer's Association.2019 Alzheimer's disease facts and figures","year":"2019","journal-title":"Alzheimers Dement"},{"key":"2020100612441520700_suaa119-B77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer's disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"2020100612441520700_suaa119-B78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathol"},{"key":"2020100612441520700_suaa119-B79","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"2020100612441520700_suaa119-B80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"2020100612441520700_suaa119-B81","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2020100612441520700_suaa119-B82","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.envres.2018.03.023","article-title":"Hallmarks of Alzheimer disease are evolving relentlessly in Metropolitan Mexico City infants, children and young adults. APOE4 carriers have higher suicide risk and higher odds of reaching NFT stage V at \u226440 years of age","volume":"164","author":"Calder\u00f3n-Garcidue\u00f1as","year":"2018","journal-title":"Environ Res"},{"key":"2020100612441520700_suaa119-B83","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"2020100612441520700_suaa119-B84","doi-asserted-by":"crossref","first-page":"e0221985","DOI":"10.1371\/journal.pone.0221985","article-title":"Self-reported health behaviors and longitudinal cognitive performance in late middle age: results from the Wisconsin Registry for Alzheimer's Prevention","volume":"15","author":"Mueller","year":"2020","journal-title":"PLoS One"},{"key":"2020100612441520700_suaa119-B85","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction\u2014the disregarded partner of Alzheimer's disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement"},{"key":"2020100612441520700_suaa119-B86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2217\/nmt.14.13","article-title":"Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: pathology, diagnosis and screening","volume":"4","author":"Davey","year":"2014","journal-title":"Neurodegener Dis Manag"},{"key":"2020100612441520700_suaa119-B87","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3233\/JAD-191046","article-title":"Neuroimaging in vascular cognitive impairment and dementia: a systematic review","volume":"73","author":"Frantellizzi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"2020100612441520700_suaa119-B88","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1474-4422(16)30029-1","article-title":"Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study","volume":"15","author":"Arvanitakis","year":"2016","journal-title":"Lancet Neurol"},{"key":"2020100612441520700_suaa119-B89","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"2020100612441520700_suaa119-B90","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1177\/0271678X15617171","article-title":"4D flow MRI for intracranial hemodynamics assessment in Alzheimer's disease","volume":"36","author":"Rivera-Rivera","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"2020100612441520700_suaa119-B91","doi-asserted-by":"crossref","first-page":"100907","DOI":"10.1016\/j.arr.2019.05.001","article-title":"Arterial stiffness and brain integrity: a review of MRI findings","volume":"53","author":"Badji","year":"2019","journal-title":"Ageing Res Rev"},{"key":"2020100612441520700_suaa119-B92","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/eurheartj\/ehz100","article-title":"Associations between vascular risk factors and brain MRI indices in UK Biobank","volume":"40","author":"Cox","year":"2019","journal-title":"Eur Heart J"},{"key":"2020100612441520700_suaa119-B93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nrl.2015.07.010","article-title":"Vascular pathology: cause or effect in Alzheimer disease?","volume":"33","author":"Rius-P\u00e9rez","year":"2018","journal-title":"Neurologia"},{"key":"2020100612441520700_suaa119-B94","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-013-1151-4","article-title":"Longitudinal change in CSF Tau and A\u03b2 biomarkers for up to 48 months in ADNI","volume":"126","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2020100612441520700_suaa119-B95","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/WNL.0000000000007543","article-title":"Blood pressure and dementia: what the SPRINT-MIND trial adds and what we still need to know","volume":"92","author":"Peters","year":"2019","journal-title":"Neurology"},{"key":"2020100612441520700_suaa119-B96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"2020100612441520700_suaa119-B97","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis","volume":"56","author":"Anstey","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2020100612441520700_suaa119-B98","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"2020100612441520700_suaa119-B99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2020100612441520700_suaa119-B100","first-page":"69","article-title":"Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis","volume":"7","author":"Santos","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2020100612441520700_suaa119-B101","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.44.2.342","article-title":"Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease","volume":"44","author":"Brousseau","year":"1994","journal-title":"Neurology"},{"key":"2020100612441520700_suaa119-B102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2009.134","article-title":"The common biological basis for common complex diseases: evidence from lipoprotein lipase gene","volume":"18","author":"Xie","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"2020100612441520700_suaa119-B103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/M15-0187","article-title":"Disclosing pleiotropic effects during genetic risk assessment for Alzheimer disease: a randomized trial","volume":"164","author":"Christensen","year":"2016","journal-title":"Ann Intern Med"},{"key":"2020100612441520700_suaa119-B104","author":"Pretorius","year":"2013"},{"key":"2020100612441520700_suaa119-B105","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1039\/C7FO01815K","article-title":"A comparative study of eicosapentaenoic acid enriched phosphatidylcholine and ethyl ester in improving cognitive deficiency in Alzheimer's disease model rats","volume":"9","author":"Wen","year":"2018","journal-title":"Food Funct"},{"key":"2020100612441520700_suaa119-B106","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1021\/acs.jafc.9b05947","article-title":"Eicosapentaenoic acid-enriched phosphatidylcholine mitigated A\u03b21-42-induced neurotoxicity via autophagy-inflammasome pathway","volume":"67","author":"Wen","year":"2019","journal-title":"J Agric Food Chem"},{"key":"2020100612441520700_suaa119-B107","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-170281","article-title":"Quantitative erythrocyte omega-3 EPA Plus DHA levels are related to higher regional cerebral blood flow on brain SPECT","volume":"58","author":"Amen","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2020100612441520700_suaa119-B108","year":"2020"},{"key":"2020100612441520700_suaa119-B109","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/eurheartj\/eht462","article-title":"Depression and cardiovascular disease: a clinical review","volume":"35","author":"Hare","year":"2014","journal-title":"Eur Heart J"},{"key":"2020100612441520700_suaa119-B110","doi-asserted-by":"crossref","first-page":"112911","DOI":"10.1016\/j.psychres.2020.112911","article-title":"Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6\/omega-3 ratio in children. A randomized, double-blind and controlled trial","volume":"287","author":"Trebatick\u00e1","year":"2020","journal-title":"Psychiatry Res"},{"key":"2020100612441520700_suaa119-B111","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized clinical trial","volume":"318","author":"Mohamed","year":"2017","journal-title":"JAMA"},{"key":"2020100612441520700_suaa119-B112","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","article-title":"Adjunctive nutraceuticals for depression: a systematic review and meta-analyses","volume":"173","author":"Sarris","year":"2016","journal-title":"Am J Psychiatry"},{"key":"2020100612441520700_suaa119-B113","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1192\/bjp.bp.114.160242","article-title":"Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression","volume":"209","author":"Hallahan","year":"2016","journal-title":"Br J Psychiatry"},{"key":"2020100612441520700_suaa119-B114","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.euroneuro.2012.08.003","article-title":"Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Mozaffari-Khosravi","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"2020100612441520700_suaa119-B115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2019.07.001","article-title":"Brain eicosapentaenoic acid metabolism as a lead for novel therapeutics in major depression","volume":"85","author":"Bazinet","year":"2020","journal-title":"Brain Behav Immun"},{"key":"2020100612441520700_suaa119-B116","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.plefa.2014.05.007","article-title":"beta-Oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels","volume":"92","author":"Chen","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2020100612441520700_suaa119-B117","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nut.2019.03.021","article-title":"Differential plasma postprandial lipidomic responses to krill oil and fish oil supplementations in women: a randomized crossover study","volume":"65","author":"Sung","year":"2019","journal-title":"Nutrition"},{"key":"2020100612441520700_suaa119-B118","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/physrev.00039.2016","article-title":"Neuroimmune interactions: from the brain to the immune system and vice versa","volume":"98","author":"Dantzer","year":"2018","journal-title":"Physiol Rev"},{"key":"2020100612441520700_suaa119-B119","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fimmu.2016.00544","article-title":"Neuron-microglia interactions in mental health disorders: \u201cfor better, and for worse\u201d","volume":"7","author":"Wohleb","year":"2016","journal-title":"Front Immunol"},{"key":"2020100612441520700_suaa119-B120","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1073\/pnas.1511003112","article-title":"Imaging robust microglial activation after lipopolysaccharide administration in humans with PET","volume":"112","author":"Sandiego","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020100612441520700_suaa119-B121","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","article-title":"Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides","volume":"42","author":"Torres-Platas","year":"2014","journal-title":"Brain Behav Immun"},{"key":"2020100612441520700_suaa119-B122","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/npp.2016.123","article-title":"Role of adiposity-driven inflammation in depressive morbidity","volume":"42","author":"Capuron","year":"2017","journal-title":"Neuropsychopharmacol"},{"key":"2020100612441520700_suaa119-B123","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","article-title":"Depression as a microglial disease","volume":"38","author":"Yirmiya","year":"2015","journal-title":"Trends Neurosci"},{"key":"2020100612441520700_suaa119-B124","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2020100612441520700_suaa119-B125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00210-009-0478-9","article-title":"Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266","volume":"381","author":"G\u00fcnther","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2020100612441520700_suaa119-B126","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/npp.2012.75","article-title":"Serotonin modulates the effects of Pavlovian aversive predictions on response vigor","volume":"37","author":"Crockett","year":"2012","journal-title":"Neuropsychopharmacol"},{"key":"2020100612441520700_suaa119-B127","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000502652","article-title":"International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder","volume":"88","author":"Guu","year":"2019","journal-title":"Psychother Psychosom"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/22\/Supplement_J\/J54\/33839430\/suaa119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/22\/Supplement_J\/J54\/33839430\/suaa119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T16:45:11Z","timestamp":1602002711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/22\/Supplement_J\/J54\/5918444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":127,"journal-issue":{"issue":"Supplement_J","published-online":{"date-parts":[[2020,10,6]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suaa119","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,10,1]]}}}